Macaques infected with attenuated simian immunodeficiency virus (SIVmac) can resist superinfection challenge with virulent virus, showing the potential of live attenuated virus as an AIDS vaccine. Superinfection resistance does not, however, prevent the generation of virulent virus in vivo, suggesting that such virus may circumvent the resistance effect. Here, we show that three macaques already infected with the attenuated molecular clone SIVmacC8 were resistant to superinfection with virulent virus that arose in vivo following repair of a 12 bp attenuating lesion in the nef/3h LTR. In contrast, four naive animals became infected following inoculation with blood taken from the macaque in which virulent virus arose. Loss of nefspecific cytotoxic T lymphocyte (CTL) responses followed repair of the attenuating lesion within nef in the donor animal, suggesting the possibility of escape from CTL-driven selection pressure.
vivo (Kestler et al., 1991 ; Quillant et al., 1993) , as may small deletions (Whatmore et al., 1995) . Even attenuated mutants carrying multiple deletions, which are therefore unlikely to revert (Wyand et al., 1996) , may induce disease in neonatal macaques (Baba et al., 1995) . Nevertheless, investigation of the mechanisms of superinfection resistance may reveal insights into lentivirus infection and immunity that may be exploitable for the design of an effective vaccine against AIDS.
At present it is not clear whether superinfection resistance is or is not an immunological effect. Several studies support the view that serum-neutralizing antibodies are important for superinfection immunity (Clements et al., 1995 ; Wyand et al., 1996 ; Van Rompay et al., 1996) . However, in a study of macaques given short-term exposure to live attenuated SIVmac, Norley et al. (1996) could find no correlation between the levels of binding or neutralizing antibodies and protection from superinfection challenge. Infection of macaques with live attenuated SIVmac also induces virus-specific cytotoxic T lymphocytes (CTL) (Dittmer et al., 1995 ; Cranage et al., 1997) . However, profound depletion of circulating CD8 + lymphocytes failed to ablate superinfection immunity in such animals (R. Stebbings, personal communication).
In the study described here, we have utilized the molecular clones derived from SIVmac32H (Rud et al., 1994) to investigate the protective mechanisms involved in superinfection resistance. Molecular clone SIVmacC8 has an attenuated phenotype in rhesus macaques. After an initial cellassociated viraemia, virus loads become much reduced and virus recovery from peripheral blood mononuclear cells (PBMC) is infrequent (Whatmore et al., 1995) . This clone is isogenic with its more virulent partner SIVmacJ5 except for a 12 bp deletion in the nef\3h LTR overlapping region (nucleotides 9501-9512) and six nucleotide substitutions, two of which result in coding changes within nef (Rud et al., 1994) . Because SIVmacC8 has only a small attenuating lesion, the virus is susceptible to mutation in vivo resulting in the restoration of full-length nef. Paradoxically, reversion to virulence, concomitant with nef repair, occurred in a SIVmacC8-infected macaque despite the animal being resistant to exogenous superinfection with virulent SIVmacJ5 (Whatmore et al., 1995) . This result suggested that in vivo-selected virulence-revertant virus may be able to bypass the super- infection resistance effect, perhaps by escape from a SIVmacC8-driven immune response. This possibility has been investigated further in the experiments described here.
Four Indian rhesus macaques had been infected with SIVmacC8 as part of a mucosal superinfection resistance study (Cranage et al., 1997) . All animals became negative or intermittent for virus isolation by week 17, seroconverted to SIV and made virus-neutralizing responses. In one animal, 29R, direct sequencing of PBMC-derived proviral DNA revealed that by week 49 after infection the 12 bp deletion associated with the attenuated phenotype had been replaced by an almost exact duplication of the upstream flanking region. This resulted in a predicted amino acid sequence of DRIL restoring nef to full-length (Whatmore et al., 1995) . Sequence analysis of plasmid clones generated at week 41 revealed that the revertant population had already arisen by this stage, with 35 % of clones having the repaired sequence and the remainder having the deleted sequence of the parental virus. Thus, the repaired sequence became predominant between weeks 41 and 49. By week 59, virus isolation from PBMC had become positive and remained so during the subsequent course of infection. Fig. 1 summarizes changes seen in the consensus sequence of the nef and 3h LTR regions occurring during the course of infection. A total of 18 base substitutions was recorded but none of these was associated with known regulatory sequence elements. All but one of the 12 base substitutions occurring in the nef ORF resulted in predicted amino acid changes. At week 111, further evolution of the repaired sequence was detected, and by this stage a 33 bp deletion in nef (nucleotides 9652-9684) had occurred. These latter nucleotide sequence changes were concurrent with the onset of clinical decline. The animal showed progressive weight loss and a decline in both CD4 + and CD8 + lymphocytes. By week 145, axillary lymph nodes were enlarged and by week 150, inguinal lymph nodes were also enlarged. Autopsy at 158 weeks after infection with SIVmacC8 revealed follicular and paracortical hyperplasia in all lymph nodes examined. The follicles of the spleen were markedly hyperplastic and hyalinization was common. Pneumocystis carinii and associated pathology was seen in the lungs.
To determine if revertant virus had circumvented superinfection resistance, three rhesus macaques that had been infected with SIVmacC8 for 93 weeks (11R, 19R and 28R) , together with four naive control animals (47T, 47S, 41S and 27S), were each inoculated intravenously with 2 ml of blood from 29R. The three animals previously infected with SIVmacC8, in which no repair of the nef deletion had occurred, had been shown to resist superinfection with SIVmacJ5 and SHIV4 (a chimeric virus of SIVmac239 expressing the HIV-1 HXB2c env, tat and rev ; Li et al., 1992) following intrarectal exposure at weeks 60 and 80 respectively (Cranage et al., 1997) .
On the day of challenge, the cell-associated virus load in the blood of 29R was found to be 10 infected cells per 10' PBMC, but cell-free virus was undetectable in plasma, even when added undiluted to indicator cells. Following challenge, the four naive macaques all became persistently viraemic (Table 1) , and the presence of 29R proviral DNA was confirmed by direct sequencing of nef, PCR-amplified from PBMC DNA. In contrast, in the SIVmacC8-infected animals virus was isolated only from animal 28R after challenge with 29R blood. Virus isolation from 28R PBMC was always slower (18-27 days) compared to isolation from PBMC of the control animals Virus recovery and PCR following challenge of macaques previously infected with attenuated virus (C8) and naive control animals (CON). PBMC were cocultured with C8166 cells and virus isolation confirmed by immunofluorescent antibody-staining (Whatmore et al., 1995) . DNA extracted from PBMC was used to distinguish vaccine and challenge virus by a nested PCR procedure using primer sets SE9044N\SN9866C and SN9272\SN9763C, as described by Rose et al. (1995) . Where PCR products were obtained, their identity was confirmed by direct sequencing of the product (Sequanase PCR product sequencing kit, Amersham) using primer SN9272N to sequence across the region of the SIVmacC8 deletion\29R repair. Numbers of weeks after challenge with blood from macaque 29R are indicated. 
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(7-15 days), probably reflecting a lower virus load. Virus was also recovered intermittently from 28R before challenge, whereas the other two infected macaques had been isolationnegative for several months prior to challenge. PCR amplification of proviral DNA from 28R and the other SIVmacC8-infected macaques failed to reveal the presence of 29R nef sequences. The failure to detect provirus in animal 28R by routine PCR screening was somewhat surprising, given that virus was isolated intermittently from this animal by culture. A PCR product could be obtained, however, when using the primer set amplifying the virtual full-length nef\3h LTR. Further investigation revealed that a deletion had occurred in the 28R nef\3h LTR, removing the binding site for primer SN9763C used in the routine PCR screening. The provirus in 28R was clearly SIVmacC8-derived as it still had the characteristic 12 bp deletion. Furthermore, SIV-specific antibodies in the SIVmacC8-infected animals were unaffected by challenge, whereas control animals developed rising titres of antibody in response to infection (data not shown). Post-mortem examination of tissues taken from animals 11R, 19R and 28R, at 26, 29 and 34 weeks respectively after challenge with blood from 29R revealed the presence of virus, and in all cases this was found to be SIVmacC8 (Cranage et al., 1997) . Taken together, these results show that there was no detectable superinfection with the 29R challenge.
Humoral immunity is unlikely to be critical for superinfection resistance. A population of viruses that had arisen to escape a SIVmacC8-specific humoral response would be expected to escape recognition in other SIVmacC8-infected animals, thereby resulting in superinfection. Furthermore, as we and others have shown, animals infected with attenuated SIVmac resist superinfection with SIVmac chimeric virus expressing HIV-1 envelope, even though HIV-1 envelopebinding or neutralizing antibodies were not detectable (Stott et al., 1994 ; Bogers et al., 1995 ; Cranage et al., 1997) . Also, passive transfer of serum from SIVmac wild-type or SIVmacC8-infected macaques failed to protect naive recipients from subsequent challenge with virulent virus (Kent et al., 1994 ; N. Almond, personal communication) . Taken together, these data strongly suggest that antibodies are not responsible for superinfection resistance in this system.
It is possible that virulent virus arose by escape from an immunodominant CTL response. CTL responses to nef can efficiently limit early virus replication and may even prevent the establishment of infection when precursor cells are present in sufficient numbers (Gallimore et al., 1995) . Consistent nefspecific CTL activity was detected in macaque 29R on four occasions when tested between weeks 50 and 61 after infection with SIVmacC8 (Table 2) . A response was detected against a pool of peptides covering the whole of the nef protein, as well as against pools of peptides covering both the amino-and carboxy-terminal halves. This response was present, therefore, at a time when virus isolation frequency became high, following the emergence of virus sequences having a fulllength nef. After week 66, nef-specific CTL activity could not be demonstrated in in vitro-restimulated PBMC against nef peptide-pulsed B cell targets or B cell targets infected with recombinant vaccinia virus expressing SIVmacJ5 nef. Despite this lack of response to nef, when tested at week 90, an envspecific CTL response was detected against target cells infected with recombinant vaccinia virus expressing SIVmacJ5 env (19 % specific lysis at an effector to target ratio of 50 : 1), suggesting that the loss of CTL activity may have been nefspecific.
The challenge experiment described here would not detect CTL-driven escape because CTL epitope recognition is MHC- Table 2 . Nef-specific CTL responses in macaque29R PBMC were restimulated in bulk culture with SIV-infected autologous phytohaemagglutinin blasts as described previously (Cranage et al., 1997) . CTL activity was determined over a range of effector to target ratios (E : T) on &"chromium-labelled herpesvirus papio-transformed B cell lines. Target cells were pulsed with peptide pools covering the whole (pool 0), the amino-terminal half (amino acids 1-131 ; pool 1) or the carboxyterminal half (amino acids 122-263 ; pool 2) of the nef sequence (20 mer peptides with 10 amino acid overlaps ; EVA777, EC programme EVA) for assays before week 80. Subsequently, target cells were infected at 5 p.f.u. per cell with recombinant vaccinia virus expressing SIV nef (vv nef ; VV9011, MRC AIDS Reagent Programme, ARP274.1). , Not done. This efficient peptide-driven restimulation method failed to reveal memory for SIVmacC8 nef-specific CTL. However, the assays were performed late in the course of infection when CD8 + cell numbers were already low and the animal was in clinical decline. Other regions of nef, where point mutations occurred, may represent CTL epitopes. Alternatively, loss of nef CTL response may have been due to functional anergy induced by peptide antagonism, for example, rather than escape mutation. The observation that macaques infected with attenuated virus are resistant to challenge with in vivo-reverted virus suggests another hypothetical model for superinfection resistance, where immune escape need not be invoked to explain the virulence-reversion effect. In this model, the resident virus occupies a critical niche, and resistance to superinfection would be dependent upon the replication dynamics of this primary virus.
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In summary, the observations of virulence-reversion late in infection with SIVmac and of superinfection resistance against reverted virus pose fundamental questions regarding SIV (HIV) infection dynamics and immunity. Dissociating the relative importance of primary replication of virus from the generation of specific and innate immune responses may prove problematic. If, however, the ability of attenuated virus to exclude incoming virus from a critical niche is the dominant mechanism of superinfection resistance, it may prove to be very difficult to exploit this effect in safe and effective vaccines for use in man.
